Kelun pharmaceutical announced the development progress of four new anti viral drugs
-
Last Update: 2020-02-17
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd., a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd (hereinafter referred to as "the company"), since the establishment of the research team of anti new viral drugs on January 21, has made every effort to promote the research of an innovative peptide drug covering the prevention and treatment effects and three generic drugs, namely, lopinavir, ritonavir tablets and oseltamivir capsules Now, the research of four drugs is going on The announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
